Haleon HLN
NYSE HLN
$10.00 +0.13 (+1.32%)
At close: Aug 21, 2026 · 4:00 PM EDT

Haleon (HLN) Cash & Equivalents Growth (3y) (2024 - 2026)

Haleon (HLN) Cash & Equivalents Growth (3y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 21.81%
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 11.05%
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -4.92%
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 7.80%
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 19.10%
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 12.11%
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 27.55%
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 13.03%
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 32.82%
10 Alkermes 8.07 Bn 7.41 Bn 397.90 Mn -8.41%

Historic Data

Download Data
DateValue
Jun 30, 2026 21.81%
Dec 31, 2025 30.28%
Dec 31, 2024 72.97%